蔡莹,赵威,高炜

• 1:北京大学第三医院心内科卫生部心血管分子生物学与调节肽重点实验室及分子心血管学教育部重点实验室

摘要(Abstract)：

<正>随着放射诊断及冠状动脉介入诊疗技术的发展、人类预期寿命的延长,使用血管内对比剂的人群逐年增加。尽管上述人群中出现肾功能不全的患者不足1%[1],但在具有慢性肾病、糖尿病、使用肾毒性药物等危险因素的患者中,使用对比剂后对比剂肾病(contrast induced nephropathy,CIN)的发生率高达25%[2],且有10%~12%最终需要肾替代治疗[1]。CIN是医院获得性急性肾损伤(acute kidney injury,AKI)的

关键词(KeyWords)： 冠状动脉造影;生物标志物;对比剂肾病

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 蔡莹,赵威,高炜

参考文献(References)：

• [1]Shaker OG,El-Shehaby A,El-Khatib M.Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography.Angiology,2010,61(8):731-736.
• [2]Tasanarong A,Hutayanon P,Piyayotai D.Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrastinduced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.BMC Nephrol,2013,14:270.
• [3]Seeliger E,Sendeski M,Rihal CS,et al.Contrast-induced kidney injury:mechanisms,risk factors,and prevention.Eur Heart J,2012,33(16):2007-2015.
• [4]Lane BR.Molecular markers of kidney injury.Urol Oncol,2013,31(5):682-685.
• [5]Cruz DN,Goh CY,Haase-Fielitz A,et al.Early Biomarkers of Renal Injury.Congest Heart Fail,2010,16(Suppl 1):S25-31.
• [6]Singer E,MarkóL,Paragas N,et al.Neutrophil gelatinaseassociated lipocalin:pathophysiology and clinical applications.Acta Physiol(Oxf),2013,207(4):663-672.
• [7]Alharazy SM,Kong N,Saidin R,et al.Neutrophil GelatinaseAssociated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Coronary Angiography.Angiology,2014,65(3):216-223.
• [8]Ling W,Zhaohui N,Ben H,et al.Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography.Nephron Clin Pract,2008,108(3):c176-181.
• [9]Mc Cullough PA,Williams FJ,Stivers DN,et al.Neutrophil gelatinase-associated lipocalin:a novel marker of contrast nephropathy risk.Am J Nephrol,2012,35(6):509-514.
• [10]Malyszko J,Bachorzewska-Gajewska H,Poniatowski B,et al.Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease.Ren Fail,2009,31(10):910-919.
• [11]Haase M,Bellomo R,Devarajan P,et al.Accuracy of neutrophil gelatinase-associated lipocalin(NGAL)in diagnosis and prognosis in acute kidney injury:a systematic review and metaanalysis.Am J Kidney Dis,2009,54(6):1012-1024.
• [12]Tangri N,Stevens LA,Schmid CH,et al.Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate.Kidney Int,2011,79(4):471-477.
• [13]Rickli H,Benou K,Ammann P,et al.Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media.Clin Nephrol,2004,61:98-102.
• [14]Briguori C,Visconti G,Rivera NV,et al.Cystatin C and contrast-induced acute kidney injury.Circulation,2010,121(19):2117-2122.
• [15]Duan SB,Liu GL,Yu ZQ,et al.Urinary KIM-1,IL-18 and Cys-c as early predictive biomarkers in gadolinium-based contrastinduced nephropathy in the elderly patients.Clin Nephrol,2013,80(5):349-354.
• [16]Droppa M,Desch S,Blase P,et al.Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty.Clin Res Cardiol,2011,100(11):1037-1043.
• [17]Negishi K,Noiri E,Doi K,et al.Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury.Am J Pathol,2009,174(4):1154-1159.
• [18]Manabe K,Kamihata H,Motohiro M,et al.Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.Eur J Clin Invest,2012,42(5):557-563.
• [19]Fujita D,Takahashi M,Doi K,et al.Response of urinary livertype fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease.Heart Vessels,2015,30(3):296-303.
• [20]王磊,蒲晓群.冠状动脉介入诊疗术后尿中性粒细胞明胶酶相关性载脂蛋白和肾损伤分子1水平的变化及早期预测对比剂肾病的价值.中华心血管病杂志,2014,42(4):301-304.
• [21]Miyauchi K,Takiyama Y,Honjyo J,et al.Upregulated IL-18expression in type 2 diabetic subjects with nephropathy:TGF-b1enhanced IL-18 expression in human renal proximal tubular epithelial cells.Diabetes Res Clin Pract,2009,83(2):190-199.
• [22]He H,Li W,Qian W,et al.Urinary interleukin?18 as an early indicator to predict contrast?induced nephropathy in patients undergoing percutaneous coronary intervention.Exp Ther Med,2014,8(4):1263-1266.
• [23]Parikh CR,Mishra J,Thiessen-Philbrook H,et al.Urinary IL-18is an early predictive biomarker of acute kidney injury after cardiac surgery.Kidney Int,2006,70(1):199-203.
• [24]Sanchez-Nio MD,Benito-Martin A,Gon?alves S,et al.TNF Superfamily:A Growing Saga of Kidney Injury Modulators.Mediators Inflamm,2010,pii:182958.
• [25]Chang CF,Lu TM,Yang WC,et al.Gene Polymorphisms of Interleukin-10 and Tumor Necrosis Factor-αAre Associated with Contrast-Induced Nephropathy.Am J Nephrol,2013,37(2):110-117.
• [26]An JN,Yoo KD,Hwang JH,et al.Circulating tumor necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction:a prospective cohort study.Nephrology(Carlton),2015,20(8):552-559.
• [27]Sato W,Sato Y.Midkine in nephrogenesis,hypertension and kidney diseases.Br J Pharmacol,2014,171(4):879-887.
• [28]Kato K,Kosugi T,Sato W,et al.Growth factor Midkine is involved in the pathogenesis of renal injury induced by protein overload containing endotoxin.Clin Exp Nephrol,2011,15(3):346-354.
• [29]Kojima H,Kosugi T,Sato W,et al.Deficiency of Growth Factor Midkine Exacerbates Necrotizing Glomerular Injuries in Progressive Glomerulonephritis.Am J Pathol,2013,182(2):410-419.
• [30]Malyszko J,Bachorzewska-Gajewska H,Koc-Zorawska E,et al.Midkine:a novel and early biomarker of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventions.Biomed Res Int,2015,2015:879509.
• [31]Chung AC,Lan HY.MicroRNAs in renal fibrosis.Front Physiol,2015,6:50.
• [32]Shi S,Yu L,Chiu C,et al.Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis.J Am Soc Nephrol,2008,19(11):2159-2169.
• [33]Ho J,Ng KH,Rosen S,et al.Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury.J Am Soc Nephrol,2008,19(11):2069-2075.
• [34]Wang N,Zhou Y,Jiang L,et al.Urinary MicroRNA-10a and MicroRNA-30d Serve as Novel,Sensitive and Specific Biomarkers for Kidney Injury.PLo S One,2012,7(12):e51140.
• [35]Gutiérrez-Escolano A,Santacruz-Vázquez E,Gómez-Pérez F.Dysregulated microRNAs involved in contrast-induced acute kidney injury in rat and human.Ren Fail,2015,37(9):1498-1506.